A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

175

Enrollment

OTHER_GOV

Sponsor class

Conditions

DRUG: 4-Nitro-N-[(1RS)-1-(4-fluorophenyl)-2-(1-ethylpiperidin-4-yl)ethyl]benzamide hydrochloride
DRUG: Mannitol

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation